Papillomavirus-like particles induce acute activation of dendritic cells

Journal of Immunology

Volumn 166, Issue 9, 2001, Pages 5346-5355

  Lenz, P ^a   Day, P M ^a   Pang, Y Y S ^a   Frye, S A ^a   Jensen, P N ^a   Lowy, D R ^a   Schiller, J T ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PAPILLOMA VIRUS LIKE PARTICLE; STRUCTURAL PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANIMAL TISSUE; ARTICLE; BONE MARROW; CELL ACTIVATION; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; IMMUNE RESPONSE; IMMUNOGENICITY; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS MORPHOLOGY; WART VIRUS;

EID: 0035340806     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.9.5346     Document Type: Article

References (70)

1. Innate immunity: The virtues of a nonclonal system of recognition
2. Innate immunity: Impact on the adaptive immune response
3. Toll-like receptors: A growing family of immune receptors that are differentially expressed and regulated by different leukocytes
4. Immunobiology of dendritic cells
5. Dendritic cells: A major story unfolds
6. Dendritic cells and the control of immunity
7. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: Down-regulation by cytokines and bacterial products
8. Antigen processing by epidermal Langerhans cells correlates with the level of biosynthesis of major histocompatibility complex class Il molecules and expression of invariant chain
9. Developmental regulation of MHC class Il transport in mouse dendritic cells
10. Bacteria-induced neo-biosynthesis, stabilization, and surface expression of functional class I molecules in mouse dendritic cells
11. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells
12. The role of dendritic cells in the induction and regulation of immunity to microbial infection
13. Virus interactions with dendritic cells
14. Migration and maturation of Langerhans cells in skin transplants and explants
15. Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ
16. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA
17. The mannose receptor mediates induction of IFN-α in peripheral blood dendritic cells by enveloped RNA and DNA viruses
18. Papillomavirus-like particle vaccines for cervical cancer
19. Papillomavirus-like particles and HPV vaccine development
20. Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic
21. Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles
22. Immunization with virus-like particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection
23. Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas
24. Nasal immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions
25. The role of papillomaviruses in anogenital cancer
26. Prevalence of human papillomavirus in cervical cancer: A worldwide prospective
27. HPV6b virus like particles are potent immunogens without adjuvant in man
28. Papillomavirus-like particles can deliver defined CTL epitopes to the MHC class I pathway
29. Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model
30. Immune response to human papillomavirus 16 L1E7 chimeric virus-like particles: Induction of cytotoxic T cells and specific tumor protection
31. Chimeric papillomavirus virus-like particles induce a murine self-antigen specific protective and therapeutic antitumor immune response
32. Induction of autoantibodies to mouse CCR5 with recombinant papillomavirus particles
33. Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy
34. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor
35. The papillomavirus minor capsid protein, L2, induces localization of the major capsid protein, L1, and the viral transcription/replication protein, E2, to PML oncogenic domains
36. Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins
37. Two antibodies that neutralize papillomaviruses by different mechanisms show distinct binding patterns at 13 Å resolution
38. Interaction of papillomaviruses with the cell surface
39. Papillomavirus capsid binding and uptake by cells from different tissues and species
40. Focus assay in mouse cells for bovine papillomavirus
41. Cytokine pattern of Langerhans cells isolated from taurine epidermal cell cultures
42. Cytokine expression by human peripheral blood dendritic cells stimulated in vitro with HIV-1 and herpes simplex virus
43. HIV-1 exposed dendritic cells show increased pro-inflammatory cytokine production but reduced IL-1ra following lipopolysaccharide stimulation
44. Ligation of CD40 on dendritic celts triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation
45. IL-12p70 production by Leishmania major-harboring human dendritic cells is a CD40/CD40 ligand-dependent process
46. Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction
47. Immune response to human papillomavirus 16 L1E7 chimeric virus-like particles: Induction of cytotoxic T cells and specific tumor protection
48. L1-specific protection from tumor challenge elicited by HPV 16 virus-like particles
49. MHC class I expression on dendritic cells is sufficient to sensitize for transplantation immunity
50. The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing
51. Whole virus influenza vaccine activates dendritic cells (DC) and stimulates cytokine production by peripheral blood mononuclear cells (PBMC) while subunit vaccines support T cell proliferation
52. CpG DNA: A potent signal for growth, activation, and maturation of human dendritic cells
53. + cytolytic T cell responses
54. The distribution of FcγR1, FcγRII and FcγRIII on Langerhans' cells and keratinocytes in normal skin
55. GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells
56. Membrane and soluble FcγRII/III modulate the antigen-presenting capacity of taurine dendritic epidermal Langerhans cells for IgG-complexed antigens
57. Characterization of expression, cytokine regulation, and effector function of the high affinity IgG receptor FcγRI (CD64) expressed On human blood dendritic cells
58. The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes
59. 6 integrin as a candidate receptor for papillomaviruses
60. Comparative analysis of integrin expression on monocyte-derived macrophages and monocyte-derived dendritic cells
61. Interleukin-6: An overview
62. IL-6 enhances the generation of cytolytic T lymphocytes in the allogeneic mixed leukocyte reaction
63. Interleukin-12 and its role in the generation of THI cells
64. Antigen-bearing Langerhans cells in skin draining lymph nodes: Phenotype and kinetics of migration
65. Langerhans cells transport Leishmania major from the infected skin to the draining lymph node for presentation to antigen-specific T cells
66. Dendritic cells enhance the differentiation of naive B cells into plasma cells in vitro
67. Inhibition of dendritic cell maturation by herpes simplex virus
68. Measles virus induces abnormal differentiation of CD40 ligand-activated human dendritic cells
69. Vaccinia virus inhibits the maturation of human dendritic cells: A novel mechanism of immune evasion
70. Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like vaccine